1 |
2024 |
Elodie A.Y. Masson, Jeanne Serrano, Elise Leger-Charnay, Niyazi Acar. Cholesterol and oxysterols in retinal neuron-glia interactions: relevance for glaucoma, Frontiers in Ophthalmology. 2024; 3: 1303649.
https://doi.org/10.3389/fopht.2023.1303649 |
2 |
2022 |
Natalia Mast, Yong Li, Irina A. Pikuleva. Increased Acetylcholine Levels and Other Brain Effects in 5XFAD Mice after Treatment with 8,14-Dihydroxy Metabolite of Efavirenz, International Journal of Molecular Sciences. 2022; 23: 7669.
https://doi.org/10.3390/ijms23147669 |
3 |
2022 |
Nicole El-Darzi, Natalia Mast, David A. Buchner, Aicha Saadane, Brian Dailey, Georgios Trichonas, Irina A. Pikuleva. Low-Dose Anti-HIV Drug Efavirenz Mitigates Retinal Vascular Lesions in a Mouse Model of Alzheimer’s Disease, Frontiers in Pharmacology. 2022; 13: 902254.
https://doi.org/10.3389/fphar.2022.902254 |
4 |
2023 |
Nicole El-Darzi, Natalia Mast, Yong Li, Brian Dailey, Min Kang, Douglas J. Rhee, Irina A. Pikuleva. The normalizing effects of the CYP46A1 activator efavirenz on retinal sterol levels and risk factors for glaucoma in Apoj−/− mice, Cellular and Molecular Life Sciences. 2023; 80: 194.
https://doi.org/10.1007/s00018-023-04848-y |